Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C

NCT02725866 · clinicaltrials.gov ↗

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Paritaprevir/ritonavir/ombitasvir
DRUG: Dasabuvir
DRUG: Ribavirin

Sponsor

AbbVie